156 related articles for article (PubMed ID: 18793421)
21. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
Ghatak S; Hascall VC; Markwald RR; Misra S
J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
Aldahish A; Kale A; Aljameeli A; Shah GV
Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
[TBL] [Abstract][Full Text] [Related]
24. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA.
Formby B; Stern R
Mol Cell Biochem; 1998 Oct; 187(1-2):23-31. PubMed ID: 9788739
[TBL] [Abstract][Full Text] [Related]
27. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
29. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis.
Goshen R; Ariel I; Shuster S; Hochberg A; Vlodavsky I; de Groot N; Ben-Rafael Z; Stern R
Mol Hum Reprod; 1996 Sep; 2(9):685-91. PubMed ID: 9239683
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin receptor increases invasion of prostate cancer cells by recruiting zonula occludens-1 and promoting PKA-mediated TJ disassembly.
Aljameeli A; Thakkar A; Shah G
Cell Signal; 2017 Aug; 36():1-13. PubMed ID: 28428082
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.
Yang K; Handorean AM; Iczkowski KA
Int J Clin Exp Pathol; 2009; 2(4):361-9. PubMed ID: 19158933
[TBL] [Abstract][Full Text] [Related]
33. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes.
McKallip RJ; Fisher M; Do Y; Szakal AK; Gunthert U; Nagarkatti PS; Nagarkatti M
J Biol Chem; 2003 Oct; 278(44):43818-30. PubMed ID: 12904302
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells.
Gee K; Kozlowski M; Kumar A
J Biol Chem; 2003 Sep; 278(39):37275-87. PubMed ID: 12867430
[TBL] [Abstract][Full Text] [Related]
35. Nuclear hyaluronidase 2 drives alternative splicing of
Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
[TBL] [Abstract][Full Text] [Related]
36. Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.
Kim JS; Bashir MM; Werth VP
J Invest Dermatol; 2012 Jul; 132(7):1825-32. PubMed ID: 22456539
[TBL] [Abstract][Full Text] [Related]
37. Expression profile of standard and variants forms of CD44 related to prostate cancer behavior.
Moura CM; Pontes J; Reis ST; Viana NI; Morais DR; Dip N; Katz B; Srougi M; Leite KR
Int J Biol Markers; 2015 Feb; 30(1):e49-55. PubMed ID: 24832177
[TBL] [Abstract][Full Text] [Related]
38. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
39. Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma.
Chew SH; Okazaki Y; Akatsuka S; Wang S; Jiang L; Ohara Y; Ito F; Saya H; Sekido Y; Toyokuni S
Free Radic Biol Med; 2017 May; 106():91-99. PubMed ID: 28185919
[TBL] [Abstract][Full Text] [Related]
40. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]